[Possibilities of improvement of prognosis in patients with type 2 diabetes mellitus after coronary interventions]
| Autor: | N P, Liamina, É S, Karpova, E V, Kotel'nikova, A N, Nosenko |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Adult
Male Reoperation Myocardial Ischemia Middle Aged Coronary Angiography Prognosis Combined Modality Therapy Severity of Illness Index Treatment Outcome Diabetes Mellitus Type 2 Fenofibrate Risk Factors Myocardial Revascularization Humans Female Angioplasty Balloon Coronary Coronary Artery Bypass Aged Dyslipidemias Hypolipidemic Agents |
| Zdroj: | Kardiologiia. 51(7) |
| ISSN: | 0022-9040 |
| Popis: | We present results of investigation of fenofibrate in patients with ischemic heart disease and type 2 diabetes mellitus after myocardial revascularization at various terms of its administration. We have shown its efficacy in correction of diabetic dyslipidemia, positive influence on clinical status and long term result of coronary intervention. We have established that early (first 7 days) prescription of fenofibrate - Tricor to patients with ischemic heart disease and type 2 diabetes mellitus after myocardial revascularization lowers number of diagnostic coronary angiograms and repeat percutaneous coronary interventions by 11% during first year of follow-up. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|